Taken together, our data indicate that synt4 phosphorylation at Ser-78 and its ensuing degradation by NO/cGMP/PKG is indeed responsible for the resistance of tumor cells to CDDP via A-SMase inhibition. The gene discussed is PRKG1; the disease is neoplasm.